Skip to main content

Table 5 MDSS-based bridges for JIA domain

From: Exploring and linking biomedical resources through multidimensional semantic spaces

Disease ProteinGene Score S
anemias erythropoietin coh = 0.500 2
psoriasis TNF human coh = 0.333 2
psoriasis fusion protein conf = 0.333 3
periodic syndrome TNF receptors coh = 1.000 2
systemic onset JIA receptors IL-6 coh = 0.114 8
rickets celiac gluten coh = 0.500 2
tuberculous infections TNF blockers infliximab conf = 0.222 2
ACLS (*) lupus coagulation inhibitor f1 = 0.500 2
third disease vaccine rubella conf = 1.000 3
diseases autoimmune tyrosine phosphatases protein coh = 0.500 2
syndrome laron insulinlike growth factor conf = 1.000 2
disorder amyloid substance amyloid f1 = 0.141 5
osteoarthrosis oa proteoglycans f1 = 0.188 3
growth failure insulinlike growth factor conf = 0.667 2
thyromegaly substance amyloid conf = 0.600 3
syndrome macrophage activation perforin coh = 0.571 4
syndrome macrophage activation cyclosporine medication f1 = 0.311 14
uveitis factors antinuclear conf = 0.171 19
systemic JIA IL-1 receptor antagonist protein conf = 0.133 2
syndrome hemophagocytic perforin coh = 0.286 2
eye disease cataract factors antinuclear conf = 0.250 15
myasthenia gravis acetylcholine receptor coh = 1.000 2
  1. Best δ-maximum scored bridges between the Disease and ProteinGene levels for the the JIA domain, using our reduction method (MDSS). Interestingness measures used are: cohesion (coh), confidence (conf) and f-measure (f1). The column S indicates the number of documents supporting each bridge.